Calico Life Sciences Announces First Participant Dosed in Phase 1b Clinical Study Evaluating ABBV-CLS-7262 for the Treatment of Vanishing White Matter Disease
Terray Therapeutics and Calico Life Sciences struck a research and development collaboration Wednesday focused on the development of small-molecule therapeutics for age-related diseases.